|
|
News Breaks
|
November 20, 2009
|
| 06:03 EDT |  | INO |
| theflyonthewall.com: | Inovio Biomedical's influenza vaccine candidates achieved good results | | Inovio Biomedical Corp. announced that a combination of its synthetic consensus H1N1, H2N2, H3N2, and H5N1 influenza vaccine candidates achieved protective antibody responses against several different influenza sub-types and strains in ferrets. In addition, ferrets immunized with Inovio’s SynConTM universal flu vaccine combinations were 100% protected against death and sickness in a challenge with the A/H1N1 swine-origin influenza. Dr. Niranjan Y. Sardesai, Inovio’s SVP, Research and Development, presented this data at the Influenza Congress USA 2009 in Washington, DC, in a presentation titled, “Development of Universal SynCon DNA Vaccines for Pandemic and Seasonal Influenza.” :theflyonthewall.com |
|
|
News For INO From The Last 14 Days Check below for free stories on INO the last two weeks.
There is 1 item on the Fly with pertinent information.
Sign up for a free trial to see the rest of the stories you've been missing. |
|
January 31, 2012
|
| 05:05 EDT | | INO |
| theflyonthewall.com: | Inovio vaccines for influenza Type A/B strains met protective antibody response |
 Subscribe for More Information :theflyonthewall.com |
|
|
|
|
|
